161
Participants
Start Date
June 30, 2011
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
AZT-3TC-LPV/r twice a day
AZT sirup (10mg/ml): 4 mg/kg or 180 mg/m2 twice daily 3TC sirup (10mg/ml): 4 mg/kg twice daily LPV/r sirup (80/20 mg/ml): 12 mg/kg twice daily
ABC-3TC-EFV once a day
ABC sirup (20mg/ml): 16 mg/kg once daily in the morning 3TC sirup (10mg/ml): 8 mg/kg once daily in the morning EFV sirup (30mg/ml): 25 mg/kg once daily in the morning before food intake
Service de maladies infectieuses - CHU Charles de Gaulle, Ouagadougou
Service de pédiatrie - CHU Yalgado Ouedraogo, Ouagadougou
CEPREF, Abidjan
FSU abobo-Avocatier, Abidjan
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
Public Research Centre Health, Luxembourg
OTHER
Ministry of Foreign Affairs, Luxembourg
UNKNOWN
University of Ouagadougou, Burkina Faso
OTHER
Programme PAC-CI, Site ANRS-MIE de Côte d'Ivoire
OTHER
Ministry of Health, Rwanda
OTHER_GOV
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
University of Bordeaux
OTHER
Institut de Sante Publique, d'Epidémiologie et de Développement
UNKNOWN
Université Montpellier
OTHER
University of Paris 5 - Rene Descartes
OTHER
Queen Fabiola Children's University Hospital
OTHER
ANRS, Emerging Infectious Diseases
OTHER_GOV